Huberman Lab

Snapshot · Huberman Lab

Essentials: The Science & Treatment of Obsessive Compulsive Disorder (OCD)

Explore episode Jul 9, 2026

Where this was said

CBT vs Placebo vs SSRIs

At 25:30 · chapter starts 25:18

The episode's most clinically significant moment arrives in this chapter. Huberman presents the findings of Dr. Blair Simpson's landmark comparison study pitting exposure-based CBT against SSRIs and placebo. Placebo produced no meaningful reduction in OCD symptoms. SSRIs produced a significant but modest improvement. CBT, however, was transformative: Y-BOCS scores dropped from approximately 25 all the way down to about 11 within just four weeks — a nearly 60% reduction in symptom severity. When SSRIs and CBT were combined, the results were almost identical to CBT alone. There was no synergistic benefit from the combination. This finding has direct clinical implications: for patients already on SSRIs, adding CBT is the priority; for patients considering treatment, CBT alone may be sufficient and may be the more powerful starting point.

Similar snapshots

Health & Fitness
Pipe broke → hydrogen sulfide studio air

Tortilla Face · Aug 10, 2026

A broken pipe filled the Bad Friends studio with what the hosts identified as hydrogen sulfide — microscopic fecal aeroparticles — that the crew denied smelling.